|
⚲
|
| Keyboard |
| Schrodinger Inc | |
|---|---|
| Ticker | SDGR |
| CIK # | 0001490978 |
| CUSIP | 80810D103 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 120 West 45th Street 17th Floor, New York, NY 10036 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Schrodinger Inc | 2018-11-14 | 107.8 M | Exemption: 506(b) · Remaining: $7,175,013 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001490978] | 10-K | |
| [0001490978] | 10-Q | |
| [0001490978] | 3 | |
| [0001490978] | 4 | |
| [0001490978] | 5 | |
| [0001490978] | 8-K | |
| [0001490978] | D | |
| [0001490978] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Portfolio Management LLC | Schrodinger Inc | [2026-04-29] | 0.0 |
| Sumitomo Mitsui Trust Group Inc | Schrodinger Inc | [2025-02-04] | 0.0 |
| Rubric Capital Management LP | Schrodinger Inc | [2024-11-13] | 5.79 |
| Ark Investment Management LLC | Schrodinger Inc | [2023-02-10] | 6.21 |
| BlackRock Inc | Schrodinger Inc | [2023-02-03] | 6.4 |
| BlackRock Inc | Schrodinger Inc | [2022-02-04] | 5.1 |
| Bill & Melinda Gates Foundation Trust | Schrodinger Inc | [2021-02-12] | 23.2 |
| Vanguard Group Inc | Schrodinger Inc | [2021-02-10] | 6.76 |
| Shaw David E | Schrodinger Inc | [2021-01-19] | 17.2 |
| Flynn James E | Schrodinger Inc | [2020-02-10] | 0.52 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Herman Jenny
Common Stock
|
2026-03-06 | Sell | 608 | $12.84 | 7,807 |
|
Lorton Kenneth Patrick
Common Stock
|
2026-03-05 | Sell | 1,222 | $12.90 | 15,764 |
|
Akinsanya Karen
Common Stock
|
2026-03-05 | Sell | 1,366 | $12.90 | 17,621 |
|
Tran Yvonne
Common Stock
|
2026-03-05 | Sell | 1,094 | $12.90 | 14,113 |
|
Jain Rachit
Common Stock
|
2026-03-05 | Sell | 1,631 | $12.90 | 21,040 |
|
Farid Ramy
Common Stock
|
2026-03-05 | Sell | 3,661 | $12.91 | 47,264 |
|
Herman Jenny
Common Stock
|
2026-03-05 | Sell | 775 | $12.85 | 9,959 |
|
Abel Robert Lorne
Common Stock
|
2026-03-04 | Sell | 1,300 | $12.81 | 16,653 |
|
Farid Ramy
Common Stock
|
2026-03-02 | Grant | 48,259 | $0.00 | |
|
Akinsanya Karen
Common Stock
|
2026-03-02 | Grant | 6,077 | $0.00 | |
|
Herman Jenny
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 8,220 | $0.00 | |
|
Friesner Richard
Common Stock
|
2026-03-02 | Option exercise | 160,527 | $3.07 | 492,818 |
|
Farid Ramy
Common Stock
|
2026-03-02 | Grant | 56,250 | $0.00 | |
|
Aklian Mannix Vartan
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 34,250 | $0.00 | |
|
Herman Jenny
Common Stock
|
2026-03-02 | Grant | 9,590 | $0.00 | |
|
Tran Yvonne
Common Stock
|
2026-03-02 | Grant | 13,788 | $0.00 | |
|
Abel Robert Lorne
Common Stock
|
2026-03-02 | Grant | 17,130 | $0.00 | |
|
Akinsanya Karen
Common Stock
|
2026-03-02 | Sell | 2,206 | $11.99 | 26,450 |
|
Akinsanya Karen
Common Stock
|
2026-03-02 | Grant | 24,250 | $0.00 | |
|
Abel Robert Lorne
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 34,250 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 229 | 65,892,405 |
| 2025-12-31 | 225 | 73,015,975 |
| 2025-09-30 | 227 | 72,602,661 |
| 2025-06-30 | 236 | 72,595,647 |
| 2025-03-31 | 222 | 65,247,284 |
| 2024-12-31 | 218 | 60,756,905 |
| 2024-09-30 | 212 | 59,649,345 |
| 2024-06-30 | 209 | 59,078,038 |
| 2024-03-31 | 228 | 61,933,509 |
| 2023-12-31 | 243 | 58,207,233 |
| 2023-09-30 | 239 | 56,771,923 |
| 2023-06-30 | 244 | 58,652,198 |